Genistein synergizes with arsenic trioxide to suppress human hepatocellular carcinoma

Dihydroartemisinin inhibits growth of pancreatic cancer cells in vitro and in vivo

(2009) Hua Chen et al.   ANTI-CANCER DRUGS

A System of Classifying Microvascular Invasion to Predict Outcome After Resection in Patients With Hepatocellular Carcinoma

(2009) Sasan Roayaie et al.   GASTROENTEROLOGY

Control of mitochondrial apoptosis by the Bcl-2 family

(2009) J. K. Brunelle et al.   JOURNAL OF CELL SCIENCE

Functional Live Cell Imaging of the Pulmonary Neuroepithelial Body Microenvironment

(2008) Ian De Proost et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways

(2008) P. Lunghi et al.   BLOOD

Multi-targeted therapy of cancer by genistein

(2008) Sanjeev Banerjee et al.   CANCER LETTERS

Bcl-2 Proteins and Apoptosis: Choose Your Partner

(2008) Gordon C. Shore et al.   CELL

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

(2008) Seetal Dodd et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Genistein selectively potentiates arsenic trioxide‐induced apoptosis in human leukemia cellsviareactive oxygen species generation and activation of reactive oxygen species‐inducible protein kinases (p38‐MAPK, AMPK)

(2008) Yolanda Sánchez et al.   INTERNATIONAL JOURNAL OF CANCER

Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs

(2008) Degui Wang et al.   INTERNATIONAL JOURNAL OF UROLOGY

Molecular targeted therapies in hepatocellular carcinoma: From pre-clinical models to clinical trials

(2008) Pippa Newell et al.   JOURNAL OF HEPATOLOGY

Sorafenib in Liver Cancer — Just the Beginning

(2008) Lewis R. Roberts   NEW ENGLAND JOURNAL OF MEDICINE